Kraig Biocraft Laboratories, Inc.
KBLB
$0.09
$0.002.82%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 148.23% | 3.11% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 124.85% | 9.85% | |||
| Operating Income | -124.85% | -9.85% | |||
| Income Before Tax | -107.91% | -21.02% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -107.91% | -21.02% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -107.91% | -21.02% | |||
| EBIT | -124.85% | -9.85% | |||
| EBITDA | -125.97% | -9.93% | |||
| EPS Basic | -100.00% | -16.67% | |||
| Normalized Basic EPS | -80.00% | -25.00% | |||
| EPS Diluted | -100.00% | -16.67% | |||
| Normalized Diluted EPS | -80.00% | -25.00% | |||
| Average Basic Shares Outstanding | 1.98% | 0.58% | |||
| Average Diluted Shares Outstanding | 1.98% | 0.58% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||